Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome-Positive (Ph plus ) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study

被引：0

作者：

Mauro, Michael J. ^{[1
]}

Cortes, Jorge E. ^{[2
]}

Kantarjian, Hagop M. ^{[2
]}

Shah, Neil P. ^{[3
]}

Bixby, Dale ^{[4
]}

Flinn, Ian W. ^{[5
]}

O'Hare, Thomas ^{[6
]}

Hu, Simin ^{[8
]}

Rivera, Victor M. ^{[8
]}

Clackson, Tim ^{[8
]}

Turner, Christopher D. ^{[8
]}

Haluska, Frank G. ^{[8
]}

Druker, Brian J. ^{[7
]}

Deininger, Michael W. ^{[6
,7
]}

Talpaz, Moshe ^{[4
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[3] Univ Calif San Francisco, San Francisco, CA 94143 USA

[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[5] Sarah Cannon Res Inst, Nashville, TN USA

[6] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[7] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[8] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2014年 / 14卷

关键词：

D O I：

10.1016/j.clml.2014.06.069

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

404

引用

页码：S137 / S138

页数：2

共 50 条

[1] SAFETY AND DURABILITY OF PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) LEUKEMIA: LONG-TERM FOLLOW-UP OF AN ONGOING PHASE 1 STUDY
Mauro, M.
Cortes, J.
Kantarjian, H.
Shah, N.
Bixby, D.
Flinn, I.
O'Hare, T.
Hu, S.
Rivera, V.
Clackson, T.
Turner, C.
Haluska, F.
Druker, B.
Deininger, Mi
Talpaz, M.
HAEMATOLOGICA, 2013, 98 : 295 - 296
[2] Safety and durability of ponatinib in patients with Philadelphia chromosome-positive (Ph plus ) leukemia: Long-term follow-up of an ongoing phase I study
Mauro, Michael J.
Cortes, Jorge E.
Kantarjian, Hagop M.
Shah, Neil P.
Bixby, Dale
Flinn, Ian
O'Hare, Thomas
Hu, Simin
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Druker, Brian J.
Deininger, Michael W. N.
Talpaz, Moshe
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[3] LONGER-TERM FOLLOW-UP OF A PHASE 1 STUDY OF PONATINIB IN PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) LEUKEMIAS
Cortes, J.
Talpaz, M.
Kantarjian, H. M.
Shah, N. P.
Bixby, D.
Flinn, I. W.
O'Hare, T.
Hu, S.
Rivera, V.
Clackson, T.
Turner, C.
Haluska, F.
Druker, B. J.
Deininger, M. W.
Mauro, M. J.
HAEMATOLOGICA, 2014, 99 : 335 - 335
[4] Long-Term Follow-up of the Efficacy and Safety of Ponatinib in Philadelphia Chromosome-Positive Leukemia Patients with the T315I Mutation
Jabbour, Elias J.
Cortes, Jorge E.
Talpaz, Moshe
Baccarani, Michele
Mauro, Michael J.
Hochhaus, Andreas
Hughes, Timothy P.
Guilhot, Francois
Deininger, Michael W.
Shah, Neil
Bixby, Dale L.
Flinn, Ian W.
O'Hare, Thomas
Lustgarten, Stephanie
Rivera, Victor M.
Santillana, Sergio
Kantarjian, Hagop M.
BLOOD, 2016, 128 (22)
[5] Longer-term follow up of a phase I study of ponatinib in patients (pts) with Philadelphia chromosome-positive (Ph plus ) leukemias.
Talpaz, Moshe
Cortes, Jorge E.
Kantarjian, Hagop M.
Shah, Neil P.
Bixby, Dale L.
Flinn, Ian
O'Hare, Thomas
Hu, Simin
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Drucker, Brian J.
Deininger, Michael W. N.
Mauro, Michael J.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[6] Long-Term Anti-Leukemic Activity of Ponatinib in Patients with Philadelphia Chromosome-Positive Leukemia: Updated Results from an Ongoing Phase 1 Study
Deininger, Michael W.
Cortes, Jorge E.
Kantarjian, Hagop M.
Shah, Neil
Bixby, Dale
Mauro, Michael J.
Flinn, Ian W.
O'Hare, Thomas
Hu, Simin
Dorer, David J.
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Druker, Brian J.
Talpaz, Moshe
BLOOD, 2012, 120 (21)
[7] Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Ravandi, Farhad
O'Brien, Susan M.
Cortes, Jorge E.
Thomas, Deborah M.
Garris, Rebecca
Faderl, Stefan
Burger, Jan A.
Rytting, Michael E.
Ferrajoli, Alessandra
Wierda, William G.
Verstovsek, Srdan
Champlin, Richard
Kebriaei, Partow
McCue, Deborah A.
Huang, Xuelin
Jabbour, Elias
Garcia-Manero, Guillermo
Estrov, Zeev
Kantarjian, Hagop M.
CANCER, 2015, 121 (23) : 4158 - 4164
[8] Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study
Arinobu Tojo
Taiichi Kyo
Kazuhito Yamamoto
Hirohisa Nakamae
Naoto Takahashi
Yukio Kobayashi
Tetsuzo Tauchi
Shinichiro Okamoto
Koichi Miyamura
Kiyohiko Hatake
Hiromi Iwasaki
Itaru Matsumura
Noriko Usui
Tomoki Naoe
Meera Tugnait
Narayana I. Narasimhan
Stephanie Lustgarten
Heinrich Farin
Frank Haluska
Kazuma Ohyashiki
International Journal of Hematology, 2017, 106 : 385 - 397
[9] Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study
Tojo, Arinobu
Kyo, Taiichi
Yamamoto, Kazuhito
Nakamae, Hirohisa
Takahashi, Naoto
Kobayashi, Yukio
Tauchi, Tetsuzo
Okamoto, Shinichiro
Miyamura, Koichi
Hatake, Kiyohiko
Iwasaki, Hiromi
Matsumura, Itaru
Usui, Noriko
Naoe, Tomoki
Tugnait, Meera
Narasimhan, Narayana I.
Lustgarten, Stephanie
Farin, Heinrich
Haluska, Frank
Ohyashiki, Kazuma
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (03) : 385 - 397
[10] Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Lim, Sung-Nam
Joo, Young-Don
Lee, Kyoo-Hyung
Kim, Dae-Young
Lee, Je-Hwan
Lee, Jung-Hee
Chi, Hyun-Sook
Yun, Sung-Cheol
Lee, Won Sik
Lee, Sang Min
Park, Seonyang
Kim, Inho
Sohn, Sang Kyun
Moon, Joon Ho
Ryoo, Hun-Mo
Bae, Sung Hwa
Hyun, Myung Soo
Kim, Min Kyoung
Kim, Hyeoung Joon
Yang, Deok-Hwan
Eom, Hyeon-Seok
Lee, Gyeong-Won
Jung, Chul Won
Won, Jong-Ho
Kim, Hawk
Lee, Jae-Hoon
Shin, Ho-Jin
Jang, Dae-Young
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : 1013 - 1020

← 1 2 3 4 5 →